SNTI holds 2026 Annual Meeting
- 20,240,055 shares voted, 64.98% of total
- Three new directors elected: Timothy Lu, Edward Mathers, Frances Schulz
- KPMG ratified as auditors for 2026
SNTI
Senti Biosciences Holdings, Inc. SEC filings
Every EDGAR filing for Senti Biosciences Holdings, Inc. (SNTI), newest first, with AI summaries and stories.
- Ticker
- SNTI
- CIK
- 1854270
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~Nov 12 ยท 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
MAJOR8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINEDEFA14ASenti Biosciences Holdings, Inc.SNTILIVE Senti Biosciences adjourns annual meeting
- Convened on 2026-10-08
- Adjourned without conducting business
- Reconvened on 2026-10-15
ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE Senti Biosciences adjourns annual meeting
- Meeting adjourned on Oct 8, 2026
- Reconvened on Oct 15, 2026
- Proxy statement filed Sep 24, 2026
ROUTINEEFFECTSenti Biosciences Holdings, Inc.SNTILIVE NOTABLEDEFM14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINE424B3Senti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINES-3/ASenti Biosciences Holdings, Inc.SNTILIVE NOTABLESCHEDULE 13D/ASenti Biosciences Holdings, Inc.SNTILIVE Ownership stake disclosure by Celadon Partners SPV 24 (amended)
Celadon Partners SPV 24, filed by
ROUTINES-3/ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINEPRER14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINEDEFA14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINEDEFA14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINEDEFA14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE NOTABLE10-QSenti Biosciences Holdings, Inc.SNTILIVE ROUTINEARSSenti Biosciences Holdings, Inc.SNTILIVE NOTABLEPREM14ASenti Biosciences Holdings, Inc.SNTILIVE NOTABLESCHEDULE 13D/ASenti Biosciences Holdings, Inc.SNTILIVE Ownership stake disclosure by Celadon Partners SPV 24 (amended)
Celadon Partners SPV 24, filed by
ROUTINES-3/ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINEDEFA14ASenti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINES-3Senti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE NOTABLE10-QSenti Biosciences Holdings, Inc.SNTILIVE ROUTINE8-KSenti Biosciences Holdings, Inc.SNTILIVE ROUTINE15-12GSenti Biosciences, Inc.SNTILIVE NOTABLESCHEDULE 13D/ASenti Biosciences, Inc.SNTILIVE Ownership stake disclosure by Celadon Partners SPV 24 (amended)
Celadon Partners SPV 24, filed by
ROUTINE424B5Senti Biosciences, Inc.SNTILIVE ROUTINE8-KSenti Biosciences, Inc.SNTILIVE ROUTINEEFFECTSenti Biosciences, Inc.SNTILIVE ROUTINEEFFECTSenti Biosciences, Inc.SNTILIVE ROUTINEEFFECTSenti Biosciences, Inc.SNTILIVE ROUTINEEFFECTSenti Biosciences, Inc.SNTILIVE ROUTINE10-K/ASenti Biosciences, Inc.SNTILIVE ROUTINES-8Senti Biosciences, Inc.SNTILIVE ROUTINES-8 POSSenti Biosciences, Inc.SNTILIVE ROUTINES-8 POSSenti Biosciences, Inc.SNTILIVE ROUTINES-8 POSSenti Biosciences, Inc.SNTILIVE ROUTINES-8 POSSenti Biosciences, Inc.SNTILIVE ROUTINEPOS AMSenti Biosciences, Inc.SNTILIVE ROUTINEPOS AMSenti Biosciences, Inc.SNTILIVE ROUTINEPOS AMSenti Biosciences, Inc.SNTILIVE ROUTINE8-K12BSenti Biosciences, Inc.SNTILIVE ROUTINEPOS AMSenti Biosciences, Inc.SNTILIVE NOTABLESCHEDULE 13D/ASenti Biosciences, Inc.SNTILIVE Ownership stake disclosure by BAYER HEALTHCARE LLC (amended)
BAYER HEALTHCARE LLC, filed by
ROUTINE8-KSenti Biosciences, Inc.SNTILIVE NOTABLESCHEDULE 13D/ASenti Biosciences, Inc.SNTILIVE Ownership stake disclosure by New Enterprise Associates 15, L.P. (amended)
New Enterprise Associates 15, L.P., filed by